Intensity Therapeutics expands at-the-market offering capacity to $60 million

INTENSITY THERAPEUTICS, INC.

Filed prospectus supplement on March 23, 2026 to increase ATM program from prior cap to $60.0 million aggregate.
ATM conducted through H.C. Wainwright & Co. as sales agent under agreement dated July 3, 2024.
Company has no obligation to sell any shares; issuances at its discretion based on market conditions.
Expanded facility aims to enhance financial flexibility for strategic priorities and capital access.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.